Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma.
Chung, Chi-Jung
Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma. [electronic resource] - International journal of molecular sciences Dec 2014 - 677-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1422-0067
10.3390/ijms16010677 doi
5-Methylcytosine--metabolism
Adult
Aged
Aged, 80 and over
Carcinoma--metabolism
DNA (Cytosine-5-)-Methyltransferase 1
DNA (Cytosine-5-)-Methyltransferases--metabolism
DNA Methylation
Female
Humans
Immunohistochemistry
Male
Middle Aged
Neoplasm Staging
Odds Ratio
Urologic Neoplasms--metabolism
Urothelium--metabolism
Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma. [electronic resource] - International journal of molecular sciences Dec 2014 - 677-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1422-0067
10.3390/ijms16010677 doi
5-Methylcytosine--metabolism
Adult
Aged
Aged, 80 and over
Carcinoma--metabolism
DNA (Cytosine-5-)-Methyltransferase 1
DNA (Cytosine-5-)-Methyltransferases--metabolism
DNA Methylation
Female
Humans
Immunohistochemistry
Male
Middle Aged
Neoplasm Staging
Odds Ratio
Urologic Neoplasms--metabolism
Urothelium--metabolism